ApoE4 makes microglia trem2bling

Michael T Heneka1

  • 1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, North Worcester, MA, USA.

Neuron
|January 19, 2023
PubMed

Insights

The ApoE-Trem2 pathway is crucial for Alzheimer's disease risk. Trem2 deficiency worsens neurodegeneration in mice carrying the ApoE4 gene, indicating a complex genetic interaction.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • The apolipoprotein E (ApoE) and triggering receptor expressed on myeloid cells 2 (Trem2) pathways are implicated in sporadic Alzheimer's disease (AD) genetics.
  • Genetic variants in ApoE and Trem2 are significant risk factors for developing AD.

Purpose of the Study:

  • To investigate the functional interaction between the ApoE-Trem2 pathway in the context of Alzheimer's disease pathogenesis.
  • To determine the impact of Trem2 deficiency on neurodegeneration in a model expressing a high-risk human ApoE variant.

Main Methods:

  • Utilized a mouse model expressing human ApoE4 with tau mutations.
  • Assessed the effects of Trem2 deficiency on neurodegenerative processes within this model.

Main Results:

  • Trem2 deficiency exacerbated neurodegeneration in tau mutant mice expressing human ApoE4.
  • This suggests a significant interplay between Trem2 and ApoE4 in AD pathology.

Conclusions:

  • The ApoE-Trem2 pathway exhibits complex interactions relevant to Alzheimer's disease.
  • Future research should consider the impact of all human ApoE variants on these molecular interactions.